EMV Stock Overview
Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
EMVision Medical Devices Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.93 |
| 52 Week High | AU$2.72 |
| 52 Week Low | AU$1.45 |
| Beta | 1.4 |
| 11 Month Change | -6.10% |
| 3 Month Change | -7.45% |
| 1 Year Change | 19.57% |
| 33 Year Change | -31.49% |
| 5 Year Change | 154.97% |
| Change since IPO | 531.15% |
Recent News & Updates
Recent updates
EMVision Medical Devices (ASX:EMV) Is Using Debt Safely
Aug 28
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24Shareholder Returns
| EMV | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -0.8% | 0.5% | 1.5% |
| 1Y | 19.6% | 14.2% | 17.2% |
Return vs Industry: EMV exceeded the Australian Medical Equipment industry which returned 14.2% over the past year.
Return vs Market: EMV exceeded the Australian Market which returned 17.2% over the past year.
Price Volatility
| EMV volatility | |
|---|---|
| EMV Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: EMV has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: EMV's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Scott Kirkland | www.emvision.com.au |
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
EMVision Medical Devices Ltd Fundamentals Summary
| EMV fundamental statistics | |
|---|---|
| Market cap | AU$164.62m |
| Earnings (TTM) | -AU$2.73m |
| Revenue (TTM) | AU$11.22m |
14.7x
P/S Ratio-60.3x
P/E RatioIs EMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMV income statement (TTM) | |
|---|---|
| Revenue | AU$11.22m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$11.22m |
| Other Expenses | AU$13.95m |
| Earnings | -AU$2.73m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 100.00% |
| Net Profit Margin | -24.33% |
| Debt/Equity Ratio | 14.0% |
How did EMV perform over the long term?
See historical performance and comparison